Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial.
Katharina Schmalstieg-BahrDavid J GladstoneEva HummersJohanna SuerbaumJeffrey S HealeyAntonia ZapfDenise KösterStefanie M WerhahnRolf WachterPublished in: The European journal of general practice (2024)
Natriuretic peptide levels and hsTnI are higher in patients with AF than without and may help select patients for AF screening, but larger trials are needed.
Keyphrases
- atrial fibrillation
- end stage renal disease
- clinical trial
- left atrial
- study protocol
- oral anticoagulants
- catheter ablation
- ejection fraction
- chronic kidney disease
- newly diagnosed
- heart failure
- left atrial appendage
- direct oral anticoagulants
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- double blind
- left ventricular
- placebo controlled
- single cell